The FDA approved Onswik, a once-weekly insulin for type 2 diabetes, but not for type 1. What the trials showed and the side effects to know.

Six states will require medical proof for Medicaid work exemptions in January, skipping a federal grace year. Who is affected and what to gather.

Lior ground cinnamon sold in six states since November is recalled over elevated lead. Check for lot GAP11304; young children face the most risk.

NYC confirmed live Legionella in 7 South Bronx cooling towers as cases reached 23. What the culture results mean for nearby households.

A rare September nor'easter is cutting power in New England. Officials urge outdoor-only generator use. Know the carbon monoxide warning signs.

A new company originating from the Universitat Autònoma de Barcelona (UAB) and the Center for Computer Vision (CVC) has developed a digital tool that helps neurosurgery teams identify the areas of the brain that need to be preserved during tumor removal. The project has been developed in collaboration with the Neurosurgery Department at Bellvitge University Hospital and the Cognition and Brain Plasticity research group at IDIBELL, and has been used to date in 31 neurosurgical procedures, 19 of which took place at Bellvitge University Hospital.

Starting in July 2029, public schools must begin phasing out ultra-processed foods under a new California law that prohibits schools from serving foods high in sugar, fat, salt and certain artificial food additives. The changes should benefit kids' health but may be challenging for schools to implement, according to a Stanford Medicine study.

Insomnia is associated with a 26% higher risk of stroke and 28% higher odds of hospital admission, according to new research in Sleep Medicine Reviews. The researchers say the findings support recognizing insomnia as an important marker of brain, mental and general health.

Changes in the composition of gut bacteria could provide an early warning of type 2 diabetes (T2D), according to new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2.

New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, makes a case for extending the indication for GLP-1 receptor agonists (GLP1-RAs) to millions more people to protect their heart health.